Digestive & Intestinal Remedies (Pharmacies) - Niger

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$4.09m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.62%, resulting in a market volume of US$4.43m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$0.14 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Niger is experiencing steady growth due to increasing customer preferences for natural and herbal remedies, as well as the rising incidence of digestive and intestinal disorders.

Customer preferences: Customers in Niger are increasingly seeking natural and herbal remedies for digestive and intestinal issues. There is a growing awareness among consumers about the potential side effects of synthetic medications, leading them to opt for more natural and holistic approaches to healthcare. This shift in preferences is driving the demand for digestive and intestinal remedies that are made from natural ingredients and have fewer side effects.

Trends in the market: The market for digestive and intestinal remedies in Niger is witnessing a trend towards the use of traditional herbal medicines. Traditional herbal remedies have been used for centuries in Niger and are considered to be effective in treating digestive and intestinal disorders. These remedies are made from locally available plants and herbs, making them more accessible and affordable for the population. The increasing popularity of traditional herbal medicines is driving the growth of the market in Niger. Another trend in the market is the rising incidence of digestive and intestinal disorders. Factors such as changing lifestyles, unhealthy diets, and stress are contributing to the increasing prevalence of digestive and intestinal issues among the population. As a result, there is a growing demand for remedies that can alleviate symptoms and provide relief from these disorders. This is driving the growth of the market in Niger.

Local special circumstances: Niger is a landlocked country in West Africa, which means that it relies heavily on imports for its pharmaceutical products. The availability and affordability of digestive and intestinal remedies in the country are influenced by factors such as transportation costs, import regulations, and currency exchange rates. These local special circumstances can impact the market dynamics and the accessibility of these remedies for the population.

Underlying macroeconomic factors: The economic development and stability of Niger play a crucial role in the growth of the Digestive & Intestinal Remedies market. Factors such as GDP growth, inflation rates, and government policies can impact the purchasing power and affordability of the population. The healthcare infrastructure and access to healthcare services also play a significant role in the demand for digestive and intestinal remedies. As the economy continues to develop and improve, the market for these remedies is expected to grow further in Niger.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.